Target intelligence / Profile preview

Plasma membrane electron transport complex (PMET)

Target
PMET
Molecular classification
Enzyme complex, Oxidoreductase
01

Overview

The Plasma membrane electron transport (PMET) complex is a multi-component redox system located in the plasma membrane of eukaryotic cells that facilitates the transfer of electrons from intracellular donors, primarily NADH and NADPH, to extracellular acceptors (Del Principe et al., 2011). This system consists of various enzymes such as NADH-cytochrome b5 reductase, NAD(P)H:quinone oxidoreductase 1 (NQO1), and the ENOX protein family, often employing ubiquinone as a mobile electron carrier (Ly & Lawen, 2003). PMET plays a vital role in maintaining the cytosolic NAD+/NADH ratio, which is essential for sustaining glycolysis, especially in cells with impaired mitochondrial respiration (Berridge & Tan, 2000). Additionally, it is involved in the regulation of intracellular pH and the regeneration of extracellular antioxidants like vitamin C and E (Crane, 2001). In pathological states, PMET is frequently overexpressed in cancer cells to support rapid growth and survival under metabolic stress, making it a target for anti-proliferative therapies (Morré & Morré, 2011). Conversely, pharmacological activation or supplementation of this system, for instance with idebenone, is used to treat mitochondrial disorders by providing an alternative pathway for electron flow (Haefeli et al., 2011).

Other names
Trans-plasma membrane electron transportTPMETPlasma membrane redox systemPMRSPlasma membrane redox chain
02

Mechanism of action

Modulation of trans-plasma membrane electron flow to regulate intracellular NAD+ levels and extracellular antioxidant status.

03

Biological functions

Redox homeostasispH regulationCell growthAntioxidant recyclingEnergy metabolism
04

Disease associations

CancerMitochondrial diseaseNeurodegenerative diseaseAging
05

Safety considerations

Induction of oxidative stressDisruption of cellular redox signalingPotential metabolic interference in non-target tissues
06

Interacting drugs

Idebenone

4 more in the full profile.

07

Biomarkers

NAD+/NADH ratioExtracellular acidification rateAscorbate levelsWST-1 reduction rate

Beyond the preview

Go deeper on Plasma membrane electron transport complex (PMET).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasma membrane electron transport complex (PMET).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call